Stockreport

IMUNON Reports 2023 Financial Results and Provides Business Update

Imunon, Inc.  (IMNN) 
PDF Conference Call Begins Today at 10:00 a.m. Eastern Time LAWRENCEVILLE, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug [Read more]